SCHEMBL23999753

SCHEMBL23999753

Cc1cc(Nc2cnc3[nH]c(-c4ccc(Nc5cc(C)nc6ccc(C#N)cc56)nc4)nc3c2)ccn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPKAPK2 P49137 2/20 0.35
▸ LRRK2 Q5S007 1/20 0.35
▸ GAK O14976 1/20 0.33
▸ RIPK2 O43353 1/20 0.33
▸ COQ8A Q8NI60 1/20 0.33
▸ NLK Q9UBE8 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ PKN1 Q16512 1/20 0.32
▸ PKN2 Q16513 1/20 0.32
▸ KIT P10721 1/20 0.32
▸ KDR P35968 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23999397 0.93 MAPKAPK2 (0.44) MAPKAPK2LRRK2GAKRIPK2COQ8A
SCHEMBL23999402 0.91 MAPKAPK2 (0.43) MAPKAPK2LRRK2GAKRIPK2COQ8A
SCHEMBL23999751 0.85 LRRK2 (0.38) MAPKAPK2LRRK2GAKRIPK2COQ8A
SCHEMBL23999407 0.85 LRRK2 (0.38) MAPKAPK2LRRK2GAKRIPK2COQ8A
SCHEMBL23999477 0.83 MAPT (0.37) KDM4EMEN1ALDH1A1MAPTHPGD
SCHEMBL23999406 0.83 MAPKAPK2 (0.52) MAPKAPK2LRRK2GAKRIPK2COQ8A
SCHEMBL23999748 0.82 MAPT (0.44) MAPKAPK2MAPTKMT2AMAPK1
SCHEMBL24010189 0.81 LRRK2 (0.37) MAPKAPK2LRRK2GAKRIPK2COQ8A
SCHEMBL23999820 0.81 TLR8 (0.41) MAPTKDR
SCHEMBL23999478 0.79 KDR (0.40) MAPKAPK2KDRGSK3BGSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 — — US disclosed
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 — — US disclosed
WO-2023081854-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2023-05-11 — — WO disclosed
WO-2021226519-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2021-11-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR MAPKAPK2 138/4885LRRK2 500/4885GAK 505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback